Quinine Sulfate Capsules 300mg
>- Quinine sulfate capsules contain quinine, an antimalarial alkaloid listed in Subheading Note 2. The capsules are put up in measured doses for retail sale, used for treatment of severe falciparum malaria. This product qualifies for tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the capsules contain quinine with other active ingredients not in Note 2
Other medicaments fall under the residual tariff item.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• >- Confirm that the product has a Health Canada DIN or an exemption for importation
• Declare the quinine sulfate strength and dosage form on the CBSA customs entry
• Be prepared to provide evidence of the product's therapeutic use if requested
Related Products under Tariff item 3004.60.00
Artemether-Lumefantrine Tablets
>- Artemether-lumefantrine tablets are a fixed-dose combination antimalarial medicament. Both active ingredients, artemether and lumefantrine, are explicitly listed in Subheading Note 2 to Chapter 30, and the product is put up in measured doses for retail sale. This qualifies it for classification under tariff item 3004.60.00 as a medicament containing antimalarial active principles.
Artesunate 50mg Injection Vials
>- Artesunate injection vials contain artesunate, an artemisinin derivative listed in Subheading Note 2, formulated as a lyophilized powder for reconstitution. The product is presented in single-dose vials for therapeutic use in severe malaria. This meets the criteria for tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Chloroquine Phosphate Tablets 250mg
>- Chloroquine phosphate tablets contain chloroquine, an antimalarial active principle explicitly listed in Subheading Note 2. The tablets are put up in blister packs in measured doses for retail sale, making them eligible for classification under tariff item 3004.60.00. This product is used for both prophylaxis and treatment of malaria.
Mefloquine Hydrochloride Tablets 250mg
>- Mefloquine hydrochloride tablets contain mefloquine, an antimalarial active principle listed in Subheading Note 2. The tablets are presented in blister packs in measured doses for retail sale, used for weekly malaria prophylaxis. This product is classifiable under tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Primaquine Phosphate Tablets 15mg
>- Primaquine phosphate tablets contain primaquine, an 8-aminoquinoline antimalarial active principle listed in Subheading Note 2. The tablets are put up in measured doses for retail sale, used for radical cure of Plasmodium vivax malaria. This product qualifies for tariff item 3004.60.00 as a medicament containing an antimalarial active principle.
Pyrimethamine 25mg Tablets
>- Pyrimethamine tablets contain pyrimethamine, an antimalarial active principle explicitly listed in Subheading Note 2. The tablets are put up in measured doses for retail sale, used for malaria treatment and toxoplasmosis. This product is classifiable under tariff item 3004.60.00 as a medicament containing an antimalarial active principle.